Mental health care contacts in patients receiving paliperidone palmitate

The study investigates people who are receiving ‘paliperidone palmitate’, a relatively new treatment for schizophrenia. It aims to describe the level of inpatient and community contacts with mental healthcare workers by patients before and after treatment, to describe the typical ‘patient pathway’ and to provide costs for this.